Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation
Objective. To compare the level of expression of the renin-angiotensin-aldosterone system (RAAS) in mice with or without the endothelin-1 receptor antagonist bosentan and to examine the potential value in blood pressure regulation. Materials and methods. Bosentan (10 mg/kg/d) and placebo were given...
Main Authors: | Bo Yang, Yun-Dai Chen, Tian-De Li, Quan-Zhou Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2010-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320309358108 |
Similar Items
-
New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010-01-01) -
Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
by: Nancy Houston Miller
Published: (2010-01-01) -
Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
by: Norman K Hollenberg
Published: (2001-03-01) -
Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
by: Luz Lozano-Maneiro, et al.
Published: (2015-11-01) -
Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus
by: Hans-Henrik Parving
Published: (2000-03-01)